Chubb Ltd’s AstraZeneca AZN Stock Holding History

Chubb Ltd’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-250,000	Closed	-$17.6M	–	16
2018 Q2	$17.6M	Hold	250,000	–	–	7.38%	8
2018 Q1	$17.5M	Hold	250,000	–	–	7.6%	5
2017 Q4	$17.4M	Hold	250,000	–	–	7.55%	5
2017 Q3	$16.9M	Hold	250,000	–	–	7.39%	6
2017 Q2	$17M	Hold	250,000	–	–	7.24%	7
2017 Q1	$15.6M	Hold	250,000	–	–	6.72%	7
2016 Q4	$13.7M	Hold	250,000	–	–	6%	10
2016 Q3	$16.4M	Hold	250,000	–	–	7.45%	5
2016 Q2	$15.1M	Hold	250,000	–	–	6.53%	5
2016 Q1	$14.1M	Buy	+250,000	New	+$15M	3.84%	11

Other funds holding AZN

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

EIP

Epoch Investment Partners New York $16.5B AUM 24.3% 1-Year Est. Return

Chubb Ltd's AZN Position: Q3 2018 in Review

Chubb Ltd sold out of AstraZeneca (AZN) in Q3 2018, closing a stake of 250,000 shares — an estimated $17.6M sold.

Chubb Ltd first reported a position in AZN in Q1 2016 and held it in 10 quarters. The position peaked at $17.6M in Q2 2018. 545 funds tracked by Wall St. Rank hold AZN as of Q3 2018.

Chubb Ltd reported no remaining AstraZeneca position as of Q3 2018 after selling out during the quarter.
Chubb Ltd sold 250,000 AstraZeneca shares in Q3 2018, an estimated $17.6M.
Chubb Ltd first reported a position in AstraZeneca in Q1 2016 and held it in 10 quarters.
Chubb Ltd's AstraZeneca position peaked at $17.6M in Q2 2018.
545 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2018.

Based on Chubb Ltd's 13F filing for Q3 2018, filed 31 Oct 2018.